Biocrine Stock

Public company
Bid
Skapa konto för att se kurser
SEK
Ask
Skapa konto för att se kurser
SEK
Latest trade
Skapa konto för att se kurser
SEK
Marknadsvärde
SEK
- 3 months
- 6 months
- 12 months
- YTD
- Previous year
- All time
↑
6 months
SEK
Price is based on the latest closing on the date indicated

Biocrine
Buy BioCrine shares
- Selling and buying shares in Biocrine AB is possible through our convenient platform for unlisted shares.
- Please contact us if you have any questions or concerns regarding shares in BioCrine AB, create an account if you want to place an order in the company.
Biocrine is connected to Euroclear, after execution of the order, the shares are delivered to your custody account at any bank or securities company.
About the share
BioCrine AB
Org. Number
556727-7933
Result after net financial items
SEK -9 803 THOUSAND
1 290 TSEK
296 885 st
SEK -9 803 THOUSAND
Current liabilities
3 629 TSEK
Long-term liabilities
-
-
10 Largest Shareholders BioCrine AB
Name
capital
Name
capital
Lars Spanberg
10,41%
Per-Olof Berggren
10,1%
Svipdag AB
5,52%
Kenth Persson
4,55%
UBP CLIENTS ASSETS - SWEDEN
4,42%
THOMAS ANDERSSON BORSTAM
4,38%
MENSURA EFENDIC
4,18%
LIMITED LIABILITY COMPANY THE MINISTER
3,47%
Per Staffan Rasjo
3,37%
Nordnet Pensionsförsäkring AB
3,21%
About the pipeline
Yngve Per-Olof Berggren
The President
Kenth Ingemar Petersson
Step 1: Place an "order"
Click on the buy or sell button.
Step 2: Signing the mandate agreement
One of our employees will contact you to confirm the order by signing a mandate agreement. This is a standardized agreement that gives us the right to complete a transaction based on your given instructions. This is signed digitally.
Step 3: Matching the orders
We match your buy or sell order against other customers' orders.
Step 4: The transaction is finalized
A contract is sent to both the buyer and the seller in the transaction with instructions on where the shares are to be delivered, the payment to be made, and other information about the business relationship.

About BioCrine
Biocrine is a Swedish biotechnology company focused on research and development in the field of diabetes and hormonal health. The company was founded in 2007 and has its headquarters in Stockholm. Biocrine works closely with leading research institutions and experts to drive innovative solutions in its field.
Research and technology
Biocrine is particularly focused on understanding the molecular mechanisms of hormone release and its role in diabetes and its complications. The company works closely with the Rolf Luft Research Center for Diabetes and Endocrinology at the Karolinska Institute, one of the world's leading research institutions in this field. Leading scientists such as Per-Olof Berggren and Suad Efendic have played a central role in developing Biocrine's research strategies.
Business model
Biocrine aims to commercialize breakthrough treatments and technologies for diabetes and related diseases. The company is engaged in both research and development and marketing of innovative biotechnology solutions. Through collaboration with both academic institutions and industry, Biocrine creates new opportunities for patients and healthcare.
Funding and future
Biocrine continues to work on developing and commercializing its technologies in research and innovation. The company has carried out several rights issues since 2023, the latest of which raised SEK 8.2 million at a valuation of SEK 326.6 million. Previously, another rights issue in 2023 generated 14 MSEK at a valuation of 284.9 MSEK.
How to buy shares in Biocrine
- Create an account on Eqvor.com
- Click on the buy button next to Biocrine in the OTC list.
- Choose how many shares you want to buy and at what price, and to which depository you want the shares delivered.
- Wait for the order to be matched.
- Send your settlement note to your bank/securities company.
- The shares land in your custody - Done!
In addition to Biocrine, we have also helped investors buy and sell shares in other exciting unlisted companies in sectors such as
Hbiotechnology and bioengineering, there are A3P Biomedical, Doktor.se, MEDS Pharmacy, Sigrid Therapeutics and Mindler. Under financial services there are Klarna, Mynt, Yabie and Billogram.
Within technology and innovation: Dirac Research, Exeger, Cascade Drives, Sana Labs, Quartr and Virtune. I the consumer and lifestyle segment: CDLP, Estrid and Marshall.
Under transport and vehicle technology there are Einride, Voi, XShore, Koenigsegg and Candela. Within energy and sustainability: Blykalla and Svea Solar.
In addition: Epidemic Sound (media), Kaunis Iron (industry), GreenGold Group (forestry), and investment companies Röko, byWiT and Nicoya.
We can also help to implement deals in other unlisted companies - even if they are not listed on the platform. Contact us if you are looking for a specific case.

Frequently asked questions and answers about Biocrine
Is Biocrine listed on the stock exchange?
No, Biocrine is not listed on the stock exchange. If you want to buy shares before listing, you can do so on Eqvor.com
Is Biocrine connected to Euroclear?
Yes, Biocrine is connected to Euroclear, which means you can keep your shares in a regular share depository.
At what price is Biocrine traded?
Log in to Eqvor.com to access the latest Biocrine courses.
When will Biocrine be listed on the stock exchange?
There is currently no explicit plan to go public.
Can I store Biocrine shares on Avanza?
Yes, you can keep the shares in a regular share depository at Avanza.
What is Biocrine's valuation?
To see the valuation of Biocrine create an account on Eqvor and you will see the current valuation at the top of this page under the heading "Market capitalization" this valuation is calculated based on the last trade in the stock.
When did Biocrine last issue shares?
To see the latest issue in Biocrine log in to Eqvor and look at the graph, where you will see a purple dot in the graph for each issue with the capital raised and the share price at each issue.